HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prompt efficacy of very low-dose rituximab on monoclonal B lymphocytosis in a rheumatoid arthritis patient.

AuthorsVincenzo Bruzzese, Cinzia Marrese, Cesare Hassan, Alessandro Andriani, Angelo Zullo
JournalInternational journal of rheumatic diseases (Int J Rheum Dis) Vol. 16 Issue 6 Pg. 764-5 (Dec 2013) ISSN: 1756-185X [Electronic] England
PMID24200218 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
Topics
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Antirheumatic Agents (administration & dosage)
  • Arthritis, Rheumatoid (diagnosis, drug therapy, immunology)
  • B-Lymphocytes (drug effects, immunology)
  • Humans
  • Infusions, Parenteral
  • Lymphocytosis (diagnosis, drug therapy, immunology)
  • Male
  • Rituximab
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: